Cargando…

Glucose variability is a marker for COVID-19 severity and mortality

OBJECTIVE: We aimed to investigate the association between glucose coefficient of variation (CV) and mortality and disease severity in hospitalized patients with coronavirus disease-19 (COVID-19). SUBJECTS AND METHODS: Retrospective cohort study in a tertiary center of patients with COVID-19 admitte...

Descripción completa

Detalles Bibliográficos
Autores principales:	Abuhasira, Ran, Grossman, Alon
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Sociedade Brasileira de Endocrinologia e Metabologia 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10118757/ https://www.ncbi.nlm.nih.gov/pubmed/36219202 http://dx.doi.org/10.20945/2359-3997000000527

Ejemplares similares

Current use of D-dimer for the exclusion of venous thrombosis in hospitalized patients
por: Karny-Epstein, Nitzan, et al.
Publicado: (2022)

A Randomized Clinical Trial of Linagliptin vs. Standard of Care in Patients Hospitalized With Diabetes and COVID-19
por: Abuhasira, Ran, et al.
Publicado: (2021)

Glucose dysregulation and repolarization variability markers are short-term mortality predictors in decompensated heart failure
por: Piccirillo, Gianfranco, et al.
Publicado: (2022)

High Glucose Variability Increases Mortality Risk in Patients with COVID-19
por: Guillermo, Arauz, et al.
Publicado: (2021)

Characteristics and clinical outcomes of patients with COVID-19 recurrent infection during the omicron variant predominance
por: Abuhasira, Ran, et al.
Publicado: (2023)

Oxygen metabolism markers as predictors of mortality in severe COVID-19
por: Oliynyk, Oleksandr V., et al.
Publicado: (2021)

C-reactive protein as a possible marker for severity and mortality of COVID-19 infection
por: Tahery, Noorollah, et al.
Publicado: (2021)

Intensive care unit capacity and mortality in older adults: a three nations retrospective observational cohort study
por: Abuhasira, Ran, et al.
Publicado: (2022)

Medical Cannabis Is Not Associated with a Decrease in Activities of Daily Living in Older Adults
por: Abuhasira, Ran, et al.
Publicado: (2023)

Association of the insulin resistance marker TyG index with the severity and mortality of COVID-19
por: Ren, Huihui, et al.
Publicado: (2020)

Serum glucose variability and brain-serum glucose ratio predict metabolic distress and mortality after severe brain injury
por: Kurtz, P, et al.
Publicado: (2009)

Does poor glucose control increase the severity and mortality in patients with diabetes and COVID-19?
por: Singh, Awadhesh Kumar, et al.
Publicado: (2020)

Meta-analysis of cardiac markers for predictive factors on severity and mortality of COVID-19
por: Wungu, Citrawati Dyah Kencono, et al.
Publicado: (2021)

Prediction of 90-day mortality in patients without diabetes by severe hypoglycemia: blood glucose level as a novel marker of severity of underlying disease
por: Tsujimoto, Tetsuro, et al.
Publicado: (2014)

Spatial Variability in COVID-19 Mortality
por: Bossak, Brian H., et al.
Publicado: (2021)

Fibromyalgia-Like Syndrome Associated with Parkinson’s Disease—A Cohort Study
por: Abuhasira, Ran, et al.
Publicado: (2019)

Uric acid variability at midlife as an independent predictor of coronary heart disease and all-cause mortality
por: Grossman, Chagai, et al.
Publicado: (2019)

Demographic variables associated with Covid-19 mortality
por: Madrazo Cabo, José Manuel, et al.
Publicado: (2020)

Medical Cannabis for Older Patients—Treatment Protocol and Initial Results
por: Abuhasira, Ran, et al.
Publicado: (2019)

Glucose variability measures and their effect on mortality: a systematic review
por: Eslami, Saeid, et al.
Publicado: (2011)

Mitral Annular Plane Systolic Excursion: An Early Marker of Mortality in Severe COVID-19
por: Jarori, Upasana, et al.
Publicado: (2020)

Complement Anaphylatoxins and Inflammatory Cytokines as Prognostic Markers for COVID-19 Severity and In-Hospital Mortality
por: Alosaimi, Bandar, et al.
Publicado: (2021)

COVID-19 pandemic – Trends in an emergency department otolaryngology service
por: Tsur, Nir, et al.
Publicado: (2021)

Serum soluble Fas ligand is a severity and mortality prognostic marker for COVID-19 patients
por: Saleki, Kiarash, et al.
Publicado: (2022)

A Prognostic Marker in COVID-19 Disease Severity and Mortality: D-Dimer/Platelet Ratio
por: Tahmaz, Alper, et al.
Publicado: (2023)

Hypocalcemia in Covid-19: A Prognostic Marker for Severe Disease
por: Raesi, Ahmad, et al.
Publicado: (2021)

The association between orthostatic hypertension and all-cause mortality in hospitalized elderly persons
por: Weiss, Avraham, et al.
Publicado: (2016)

Association of Blood Glucose Variability with Sepsis-Related Disseminated Intravascular Coagulation Morbidity and Mortality
por: Liu, Dan, et al.
Publicado: (2022)

Glucose dysregulation and its association with COVID-19 mortality and hospital length of stay
por: Mirabella, Steven, et al.
Publicado: (2022)

A novel model to predict severe COVID-19 and mortality using an artificial intelligence algorithm to interpret chest radiographs and clinical variables
por: Munera, Nicolás, et al.
Publicado: (2022)

Endothelium Activation Markers in Severe Hospitalized COVID-19 Patients: Role in Mortality Risk Prediction
por: Marchetti, Marina, et al.
Publicado: (2021)

Herbal Cannabis Use Is Not Associated with Changes in Levels of Endocannabinoids and Metabolic Profile Alterations among Older Adults
por: Abuhasira, Ran, et al.
Publicado: (2022)

THE ASSOCIATION OF INFLAMMATORY MARKER LEVELS ON SEVERITY OF INFECTION AND IN-HOSPITAL MORTALITY AMONG COVID-19 CONFIRMED PATIENTS
por: Macahilas, S.A., et al.
Publicado: (2023)

Increasing Blood Glucose Variability Is a Precursor of Sepsis and Mortality in Burned Patients
por: Pisarchik, Alexander N., et al.
Publicado: (2012)

Effects of climate variables on the COVID-19 mortality in Bangladesh
por: Karim, Rezaul, et al.
Publicado: (2022)

Longitudinal variability in mortality predicts COVID-19 deaths
por: Lundberg, Jon O., et al.
Publicado: (2021)

Peripheral Plasma Cells Associated with Mortality Benefit in Severe COVID-19: A Marker of Disease Resolution
por: Boulanger, Mary, et al.
Publicado: (2021)

Plasma glucose levels and diabetes are independent predictors for mortality in patients with COVID-19
por: Long, Hui, et al.
Publicado: (2022)

Glycemic Gap as a Useful Surrogate Marker for Glucose Variability and Progression of Diabetic Retinopathy
por: Hsing, Shi-Chue, et al.
Publicado: (2021)

Variables Associated with 30-Day Mortality in Very Elderly COVID-19 Patients
por: Xing, Yunli, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_gsh1jt8rmme1dokkipkna2ns0p